Financials

  • Market Capitalization 1.16 B
  • Employee 27
  • Founded 2015
  • CEO N/A
  • Website www.lbpharma.us
  • Headquarter Delaware, United States
  • FIGI BBG00XNP5MQ4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.11
Rapporto prezzo/fatturato
77.13

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2287
VOR
Vor Biopharma Inc. - Common Stock
19.80 USD-0.50%+5.04%-11.57%+51.15%1.17 B USD
2288
TYRA
Tyra Biosciences, Inc. - Common Stock
19.60 USD-1.71%-6.35%-16.95%+36.68%1.17 B USD
2302
BCAX
Bicara Therapeutics Inc. - Common Stock
17.33 USD-0.97%-0.57%-24.26%+20.01%1.15 B USD
2313
NBTX
Nanobiotix S.A. - ADSs
23.40 USD-1.18%-7.98%-35.00%-12.23%1.13 B USD